Conclusion of a non-exclusive discount agreement pursuant to 130a para. 8 SGB V for the active ingr

Tender Notice

Tender Detail
Conclusion of a non-exclusive discount agreement pursuant to 130a para. 8 SGB V for the active ingredient galcanezumab, ATC N02CD02, for the period 01.04.2026 - 31.03.2028
Tendering Authority
Tender Category
Other
Publish Date
19 Feb 2026
Deadline
05 Feb 2026
Country
Germany
TenderNews Ref. No.
4456516260219-0
Document Fees
Refer Document.
EMD
Refer Document.
Tender Value
Refer Document.
« Previous Tender      Next Tender »

Some of Our Valuable Clients